172 related articles for article (PubMed ID: 22881604)
1. Development of a peptidase-resistant substrate for single-cell measurement of protein kinase B activation.
Proctor A; Wang Q; Lawrence DS; Allbritton NL
Anal Chem; 2012 Aug; 84(16):7195-202. PubMed ID: 22881604
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of peptide reporters in cell lysates and single cells.
Proctor A; Wang Q; Lawrence DS; Allbritton NL
Analyst; 2012 Jul; 137(13):3028-38. PubMed ID: 22314840
[TBL] [Abstract][Full Text] [Related]
3. Development of a protease-resistant reporter to quantify BCR-ABL activity in intact cells.
Proctor A; Zigoneanu IG; Wang Q; Sims CE; Lawrence DS; Allbritton NL
Analyst; 2016 Oct; 141(21):6008-6017. PubMed ID: 27704073
[TBL] [Abstract][Full Text] [Related]
4. Photoactivatable Reporter to Perform Multiplexed and Temporally Controlled Measurements of Kinase and Protease Activity in Single Cells.
Anttila MM; Vickerman BM; Wang Q; Lawrence DS; Allbritton NL
Anal Chem; 2021 Dec; 93(49):16664-16672. PubMed ID: 34865468
[TBL] [Abstract][Full Text] [Related]
5. A quantitative single-cell assay for protein kinase B reveals important insights into the biochemical behavior of an intracellular substrate peptide.
Li H; Sims CE; Kaluzova M; Stanbridge EJ; Allbritton NL
Biochemistry; 2004 Feb; 43(6):1599-608. PubMed ID: 14769036
[TBL] [Abstract][Full Text] [Related]
6. β-Turn sequences promote stability of peptide substrates for kinases within the cytosolic environment.
Yang S; Proctor A; Cline LL; Houston KM; Waters ML; Allbritton NL
Analyst; 2013 Aug; 138(15):4305-11. PubMed ID: 23785707
[TBL] [Abstract][Full Text] [Related]
7. Selection and optimization of enzyme reporters for chemical cytometry.
Proctor A; Wang Q; Lawrence DS; Allbritton NL
Methods Enzymol; 2019; 622():221-248. PubMed ID: 31155054
[TBL] [Abstract][Full Text] [Related]
8. Measurement of protein kinase B activity in single primary human pancreatic cancer cells.
Proctor A; Herrera-Loeza SG; Wang Q; Lawrence DS; Yeh JJ; Allbritton NL
Anal Chem; 2014 May; 86(9):4573-80. PubMed ID: 24716819
[TBL] [Abstract][Full Text] [Related]
9. A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase.
Owens SE; Graham WV; Siccardi D; Turner JR; Mrsny RJ
Pharm Res; 2005 May; 22(5):703-9. PubMed ID: 15906163
[TBL] [Abstract][Full Text] [Related]
10. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB
Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615
[TBL] [Abstract][Full Text] [Related]
11. Identification of efficient pentapeptide substrates for the tyrosine kinase pp60c-src.
Nair SA; Kim MH; Warren SD; Choi S; Songyang Z; Cantley LC; Hangauer DG
J Med Chem; 1995 Oct; 38(21):4276-83. PubMed ID: 7473555
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship studies of peptidomimetic PKB/Akt inhibitors: the significance of backbone interactions.
Tal-Gan Y; Freeman NS; Klein S; Levitzki A; Gilon C
Bioorg Med Chem; 2010 Apr; 18(8):2976-85. PubMed ID: 20347317
[TBL] [Abstract][Full Text] [Related]
13. Metabolic stability of peptidomimetics: N-methyl and aza heptapeptide analogs of a PKB/Akt inhibitor.
Tal-Gan Y; Freeman NS; Klein S; Levitzki A; Gilon C
Chem Biol Drug Des; 2011 Nov; 78(5):887-92. PubMed ID: 21824328
[TBL] [Abstract][Full Text] [Related]
14. Characterization of TAT-mediated transport of detachable kinase substrates.
Soughayer JS; Wang Y; Li H; Cheung SH; Rossi FM; Stanbridge EJ; Sims CE; Allbritton NL
Biochemistry; 2004 Jul; 43(26):8528-40. PubMed ID: 15222764
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
[TBL] [Abstract][Full Text] [Related]
16. Design of peptidase-resistant peptide inhibitors of myosin light chain kinase.
Khapchaev AY; Kazakova OA; Samsonov MV; Sidorova MV; Bushuev VN; Vilitkevich EL; Az'muko AA; Molokoedov AS; Bespalova ZD; Shirinsky VP
J Pept Sci; 2016 Nov; 22(11-12):673-681. PubMed ID: 27699916
[TBL] [Abstract][Full Text] [Related]
17. Proteolysis of endomorphin-1 by brain synaptic membrane-associated peptidases.
Wu L; Chen J; Zhong D; Lin C; Wang X
Acta Neurobiol Exp (Wars); 2002; 62(1):1-5. PubMed ID: 12004568
[TBL] [Abstract][Full Text] [Related]
18. Microwave-assisted solid-phase aza-peptide synthesis: aza scan of a PKB/Akt inhibitor using aza-arginine and aza-proline precursors.
Freeman NS; Tal-Gan Y; Klein S; Levitzki A; Gilon C
J Org Chem; 2011 May; 76(9):3078-85. PubMed ID: 21410283
[TBL] [Abstract][Full Text] [Related]
19. Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.
Landgraf KE; Santell L; Billeci KL; Quan C; Young JC; Maun HR; Kirchhofer D; Lazarus RA
J Biol Chem; 2010 Dec; 285(51):40362-72. PubMed ID: 20937841
[TBL] [Abstract][Full Text] [Related]
20. Peptide bond cleavage site determination of novel proteolytic enzymes found in ROS 17/2.8 cell lysates.
Guidon PT; Perrin D; Harrison P
J Cell Physiol; 1996 Feb; 166(2):407-12. PubMed ID: 8592001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
